May 2016 FDA Recall Drug by Valeant Pharmaceuticals North America Llc
D-1032-2016 - Labeling

This Class III drug recall was voluntarily initiated by Valeant Pharmaceuticals North America Llc on May 23, 2016 for the product Drug. The FDA reported the reason for recall as labeling. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1032-2016

Reason for Recall
Labeling: Not Elsewhere Classified: correctly labeled bottles were packaged in cartons that were mislabeled with an incorrect active ingredient, phenylephrine rather than pseudoephedrine, on the carton face and carton top.
Initiated
05-23-2016
Reported
06-22-2016
Quantity
3827 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Valeant Pharmaceuticals North America LLC
Lodrane D (Brompheniramine maleate 4 mg and Pseudoephedrine HCl 60 mg) Capsules, 60-count bottles, Distributed by: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807, UPC 0 00950 86006 8.

Batch or Lot Expiration Information

Lot# 's P0230-022R, P0230-023R, Exp 06/17